ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed
Dongmei Diao
Matched on ORCID iD 0000-0003-3184-9982; OpenAlex author ID A5035178722. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2012: 1 paper · 2013: 1 paper · 2014: 1 paper
Papers 3
- High glucose-induced resistance to 5-fluorouracil in pancreatic cancer cells alleviated by 2-deoxy-D-glucose. First author DOI 10.3892/br.2013.211↗
- Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis. First author DOI 10.7150/ijms.5547↗
- [Responses of pancreatic cancer cells to stimulations by nerve growth factor and the role of Trk-A expression]. Co-author PMID 22445970↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yongchun Song · 3 shared papers, 2012–2014 · strength 0.13
- Paper High glucose-induced resistance to 5-fluorouracil in pancreatic cancer cells alleviated by 2-deoxy-D-glucose. DOI 10.3892/br.2013.211↗
- Paper Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis. DOI 10.7150/ijms.5547↗
- Paper [Responses of pancreatic cancer cells to stimulations by nerve growth factor and the role of Trk-A expression]. PMID 22445970↗
- Chengxue Dang · 3 shared papers, 2012–2014 · strength 0.13
- Paper High glucose-induced resistance to 5-fluorouracil in pancreatic cancer cells alleviated by 2-deoxy-D-glucose. DOI 10.3892/br.2013.211↗
- Paper Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis. DOI 10.7150/ijms.5547↗
- Paper [Responses of pancreatic cancer cells to stimulations by nerve growth factor and the role of Trk-A expression]. PMID 22445970↗
- Yao Cheng · 2 shared papers, 2013–2014 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.